STAT+: Pharmalittle: Low-income Part D beneficiaries without subsidies often don’t fill scripts; Pfizer strikes a deal for RSV drugs

Many lower-income Medicare Part D beneficiaries who do not receive subsidies — which can cap or lower out-of-pocket costs — did not fill their prescriptions.

Hello, everyone, and how are you today? Gray skies are hovering over the chilly Pharmalot campus this morning, but our spirits remain sunny. And why not? Once again, we are reminded of a favorite bit of wisdom from the Morning Mayor: “Every new day should be unwrapped like a precious gift.” So go ahead — tug on the ribbon, and join us for a delicious cup of stimulation. Our choice today is glazed doughnut. Yes, this is real. Meanwhile, here are some items of interest to get you going. Hope you have a smashing day, and do stay in touch. …

Medicare Part D beneficiaries who have low incomes and receive government subsidies were nearly twice as likely to fill a prescription for a high-priced medicine for cancer or other illnesses compared with Americans who don’t receive such support, STAT writes, citing a new study. The analysis found that many beneficiaries who do not receive subsidies — which can cap or lower out-of-pocket costs — did not fill their prescriptions. For instance, 30% of prescriptions for cancer drugs were not filled, and more than 50% of prescriptions written for medicines used to treat high cholesterol or immune disorders also went unfilled.

Continue to STAT+ to read the full story…